{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:07:23Z","timestamp":1791086843595,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2000,3]]},"DOI":"10.1007\/bf03032653","type":"journal-article","created":{"date-parts":[[2009,9,27]],"date-time":"2009-09-27T19:36:53Z","timestamp":1254080213000},"page":"18-23","source":"Crossref","is-referenced-by-count":30,"title":["Detection of TNF\u03b1 expression in the bone marrow and determination of TNF\u03b1 production of peripheral blood mononuclear cells in myelodysplastic syndrome"],"prefix":"10.1007","volume":"6","author":[{"given":"Lenke","family":"Moln\u00e1r","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00edmea","family":"Berki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alizadeh","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"N\u00e9meth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajna","family":"Losonczy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF03032653_CR1","first-page":"13","volume":"29","author":"M Alexandrakis","year":"1998","unstructured":"Alexandrakis M, Coulocheri S, Xylouri I, et al: Elevated serum TNF-\u03b1 concentrations are predictive of shortened survival in patients with high-risk myelodysplastic syndromes. Haematologia 29:13\u201324, 1998.","journal-title":"Haematologia"},{"key":"BF03032653_CR2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF00666476","volume":"29","author":"Zs Beb\u00f4k","year":"1994","unstructured":"Beb\u00f4k Zs, M\u00e1rkus B, N\u00e9meth P: Prognostic relevances of transforming growth factor alpha (TGF\u03b1) and tumor necrosis factor alpha (TNF\u03b1) detected in breast cancer tissues by immunohistochemistry. Breast Cancer Res Treat 29:229\u2013235, 1994.","journal-title":"Breast Cancer Res Treat"},{"key":"BF03032653_CR3","doi-asserted-by":"crossref","first-page":"4487","DOI":"10.4049\/jimmunol.136.12.4487","volume":"136","author":"HE Broxmeyer","year":"1986","unstructured":"Broxmeyer HE, Williams DE, Lu I, et al: The suppressive influence of human tumor necrosis factor on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergysm of tumor necrosis factor and interferon-gamma. J Immunol 136, 4487\u20134495, 1986.","journal-title":"J Immunol"},{"key":"BF03032653_CR4","first-page":"81","volume-title":"Molecular biology and apoptosis in myelodysplastic syndromes","author":"P Feneaux","year":"1998","unstructured":"Feneaux P: Molecular biology and apoptosis in myelodysplastic syndromes. ISH-EHA, Amsterdam, Education Session, 81\u201384, 1998."},{"key":"BF03032653_CR5","first-page":"26","volume":"6","author":"A Ganser","year":"1998","unstructured":"Ganser A: Myelodysplastic syndromes (MDS): therapeutic drug interactions in the anti-death programme. Trends in OncoHemat. 6. 26\u201329, 1998.","journal-title":"Trends in OncoHemat"},{"key":"BF03032653_CR6","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1046\/j.1365-2141.1998.00933.x","volume":"103","author":"GM Gersuk","year":"1998","unstructured":"Gersuk GM, Beckham C, Loken MR, et al: A role for tumour necrosis factor-\u03b1, Fas and Fas-ligand in marrow failure associated with myelodysplastic syndrome. Br J Haemat 103:176\u2013188, 1998.","journal-title":"Br J Haemat"},{"key":"BF03032653_CR7","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1084\/jem.172.1.391","volume":"172","author":"J Han","year":"1990","unstructured":"Han J, Thompson P, Beutler B: Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin\/tumor necrosis factor synthesis at separate points in the signaling pathway. J Exp Med 172:391\u2013394, 1990.","journal-title":"J Exp Med"},{"key":"BF03032653_CR8","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1038\/sj.leu.2400844","volume":"11","author":"M Kitagawa","year":"1997","unstructured":"Kitagawa M, Saito I, Kuwata T, et al: Overexpression of tumor necrosis factor (TNF)-\u03b1 and interferon (IFN) -\u03b3 by bone marrow cells from patients with myelodysplastic syndromes. Leukemia 11:2049\u20132054, 1997.","journal-title":"Leukemia"},{"key":"BF03032653_CR9","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/0145-2126(95)00044-O","volume":"19","author":"M Koike","year":"1995","unstructured":"Koike M, Ishiyama T, Tomoyasu S, et al: Spontaneous cytokine overproduction by peripheral blood mononuclear cells from patients with myelodysplastic syndromes and aplastic anemia. Leuk Res 19:639\u2013644, 1995.","journal-title":"Leuk Res"},{"key":"BF03032653_CR10","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1182\/blood.V90.9.3364","volume":"90","author":"AF List","year":"1997","unstructured":"List AF, Brasfield F, Heaton R, et al: Stimulation of hematopoiesis by amifostine in patients with myelodysplastic syndrome. Blood 90:3364\u20133369, 1997.","journal-title":"Blood"},{"key":"BF03032653_CR11","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1182\/blood.V85.11.3183.bloodjournal85113183","volume":"85","author":"J Maciejewski","year":"1995","unstructured":"Maciejewski J, Selleri C, Anderson S, et al: Fas antigen expression on CD34+ human marrow cells is induced by interferon \u03b3 and tumor necrosis factor and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood 85:3183\u20133190, 1995.","journal-title":"Blood"},{"key":"BF03032653_CR12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/339027a0","volume":"339","author":"D Metcalf","year":"1989","unstructured":"Metcalf D: The molecular control of cell division, differentiation commitent and maturation in haemopoietic cells. Nature 339:27\u201330, 1989.","journal-title":"Nature"},{"key":"BF03032653_CR13","unstructured":"Musto P, Sanpaolo G, D\u2019Arena G, et al. Serum levels of cytokines with hematopoietic activity in myelodysplastic syndromes (MDS). Brit J Haemat 102\/1, suppl, 343 1998."},{"key":"BF03032653_CR14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2141.1995.tb03375.x","volume":"90","author":"K Ogata","year":"1995","unstructured":"Ogata K, Tamura H, Yokose N, et al: Effects of interleukin-12 on natural killer cell cytotoxicity and the production of interferon-\u03b3 and tumour necrosis factor-\u03b1 in patients with myelodysplastic syndromes. Br J Haemat 90:15\u201321, 1995.","journal-title":"Br J Haemat"},{"key":"BF03032653_CR15","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1365-2141.1993.tb04661.x","volume":"83","author":"S Ohmori","year":"1993","unstructured":"Ohmori S, Ohmori M, Yamagishi M, et al: MDS-macrophage derived inhibitory activity on myelopoiesis of MDS abnormal clones. Br J Haemat 83:388\u2013391, 1993.","journal-title":"Br J Haemat"},{"key":"BF03032653_CR16","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1046\/j.1365-2141.1998.01114.x","volume":"103","author":"JE Parker","year":"1998","unstructured":"Parker JE, Foshlock KL, Mijovic A, et al: \u2018Low risk\u2019 myelodysplastic syndrome is associated with excessive apoptosis and an increased ratio of proversus anti-apoptotic bcl-2-related proteins. Br J Haematol 103:1075\u20131082, 1998.","journal-title":"Br J Haematol"},{"key":"BF03032653_CR17","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1046\/j.1365-2141.1997.4373247.x","volume":"99","author":"CM Peddie","year":"1997","unstructured":"Peddie CM, Wolf R, McLellan LI, et al: Oxidative DNA damage in CD34+ myelodysplastic cells is associated with intracellular redox changes and elevated plasma tumour necrosis factorconcentration. Br J Haemat 99:625\u2013631, 1997.","journal-title":"Br J Haemat"},{"key":"BF03032653_CR18","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1182\/blood.V88.11.4275.4275","volume":"88","author":"R Rajapaksa","year":"1996","unstructured":"Rajapaksa R, Ginzton N, Rott LS, et al: Altered oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cells. Blood 88:4275\u20134287, 1996.","journal-title":"Blood"},{"key":"BF03032653_CR19","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1182\/blood.V86.1.268.bloodjournal861268","volume":"86","author":"A Raza","year":"1995","unstructured":"Raza A, Gezer S, Mundle S, et al: Apoptosis in the bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood 86:268\u2013276, 1995.","journal-title":"Blood"},{"key":"BF03032653_CR20","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0145-2126(96)00027-6","volume":"20","author":"A Raza","year":"1996","unstructured":"Raza A, Gregory SA, Preisler HD: The myelodysplastic syndromes in 1996: complex stem cell disorders confounded by dual actions of cytokines. Leuk Res 20:881\u2013890, 1996.","journal-title":"Leuk Res"},{"key":"BF03032653_CR21","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/ajh.2830480302","volume":"48","author":"A Raza","year":"1995","unstructured":"Raza A, Mundle S, Iftikar A, et al: Simultaneous assessment of cell kinetics and programmed cell death in bone marrow biopsies of myelodysplastic syndrome reveals extensive apoptosis as the probable basis for ineffective hematopoiesis. Am J Hemat 48:143\u2013154, 1995.","journal-title":"Am J Hemat"},{"key":"BF03032653_CR22","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.1073\/pnas.93.10.4742","volume":"93","author":"I Sachs","year":"1996","unstructured":"Sachs I: The control of hematopoiesis and leukemia: from basic biology to the clinic Proc Natl Acad Sci USA 93:4742\u20134749, 1996.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF03032653_CR23","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1365-2141.1993.tb03157.x","volume":"84","author":"G Seipelt","year":"1993","unstructured":"Seipelt G, Ganser A, Duranceyk H, et al: Induction of TNF-\u03b1 in patients with myelodysplastic syndromes undergoing treatment with interleukin-3. Brit J Haemat 84:749\u2013751, 1993.","journal-title":"Brit J Haemat"},{"key":"BF03032653_CR24","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0145-2126(96)00008-2","volume":"20","author":"V Shetty","year":"1996","unstructured":"Shetty V, Mundle S, Alvi S, et al: Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes. Leuk Res 20:891\u2013900, 1996.","journal-title":"Leuk Res"},{"key":"BF03032653_CR25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2257.1997.tb00007.x","volume":"19","author":"R Stasi","year":"1997","unstructured":"Stasi R, Brunetti M, Bussa S, et al: Serum levels of tumour necrosis factor-alpha predict response to recombinant human erythropoietin in patients with myelodysplastic syndrome. Clin Lab Haematol 19:197\u2013201, 1997.","journal-title":"Clin Lab Haematol"},{"key":"BF03032653_CR26","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1038\/sj.leu.2401538","volume":"13","author":"P Tsoplou","year":"1999","unstructured":"Tsoplou P, Kouraklis-Symoenidis A, Thanopoulou E, et al: Apoptosis in patients with myelodysplastic syndromes: differential involvement of marrow cells in \u2018good\u2019 versus \u2018poor\u2019 prognosis patients and correlation with apoptosis-related genes. Leukemia 13:1554\u20131563, 1999.","journal-title":"Leukemia"},{"key":"BF03032653_CR27","first-page":"1268","volume":"6","author":"GEG Verhoef","year":"1992","unstructured":"Verhoef GEG, De Schouwer P, Ceuppens JL, et al: MA: Measurement of serum cytokine levels in patients with myelodysplastic syndromes. Leukemia 6:1268\u20131272, 1992.","journal-title":"Leukemia"},{"key":"BF03032653_CR28","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2141.1993.tb03056.x","volume":"84","author":"G Visani","year":"1993","unstructured":"Visani G, Zauli G, Tosi P, et al: Impairment of GM-CSF production in myelodysplastic syndromes Br J Haemat 84:227\u2013231, 1993.","journal-title":"Br J Haemat"},{"key":"BF03032653_CR29","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0145-2126(99)00094-6","volume":"23","author":"Y Yoshida","year":"1999","unstructured":"Yoshida Y, Mufti GJ: Apoptosis and its significance in MDS: controversies revisited. Leuk. Res 23:777\u2013785, 1999.","journal-title":"Leuk. Res"},{"key":"BF03032653_CR30","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1182\/blood.V77.2.413.413","volume":"77","author":"N Zoumbos","year":"1991","unstructured":"Zoumbos N, Symeonidis A, Kourakli A, et al: Increased levels of soluble interleukin-2 receptors and tumor necrosis factor in serum of patients with myelodysplastic syndromes. Blood 77:413\u2013414, 1991.","journal-title":"Blood"}],"container-title":["Pathology & Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03032653.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03032653\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03032653","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T22:47:29Z","timestamp":1685141249000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03032653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,3]]}},"alternative-id":["BF03032653"],"URL":"https:\/\/doi.org\/10.1007\/bf03032653","relation":{},"ISSN":["1219-4956"],"issn-type":[{"value":"1219-4956","type":"print"}],"subject":[],"published":{"date-parts":[[2000,3]]}}}